Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book. If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
Get up-to-the-minute Globe Business Updates   |  More Business News
	ADVERTISEMENT Monday, March 29, 2010 Chamber chooses Gallery as next chair The Greater Boston Chamber of Commerce said that Robert Gallery, Bank of America Massachusetts president, has been chosen to serve as the chamber's new chair. NStar gets state OK on smart grid pilot program NStar, the Boston company that transmits and delivers electricity and natural gas to 1.4 million customers in Eastern and Central Massachusetts, said its Smart Grid pilot program has been approved by the Massachusetts Department of Public Utilities. Integro is moving to Two Financial Center The Boston office of Lincoln Property Co. said it has brokered a new 5,805-square-foot office lease to Integro Insurance Brokers at Two Financial Center, a 220,000 office building in Boston's Financial District. Mass. gas prices are unchanged The average price for gas in Massachusetts held steady at $2.719 a gallon in the latest weekly AAA survey, AAA Southern New England said today. BIOCIUS is moving to Wakefield BIOCIUS Life Sciences Inc., which provides the biopharmaceutical industry with products and services designed to speed and accuracy in drug discovery, said it is planning to relocate from Woburn to larger quarters about five miles away in Wakefield. Large Midwest health system taps eClinicalWorks Advocate Physician Partners, a large Illinois-based health system, said it is partnering with eClinicalWorks of Westborough to implement an electronic medical record system. PerkinElmer ready to test Chinese herbal medicines PerkinElmer Inc., the Waltham life sciences company, said today that its broad portfolio of analytical solutions are well suited for testing the quality and safety of traditional Chinese herbal medicines. Pro-Pharmaceuticals grants DAVANAT license Pro-Pharmaceuticals Inc. said it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT to treat cancer in Colombia, South America. Leukemia & Lymphoma Society partners with Avila The Leukemia & Lymphoma Society and Avila Therapeutics Inc. have established a collaboration to support development of one of Avila's lead product candidates, AVL-292, for treatment of adults with B cell cancers, the two said today. Today in Globe Business A round-up of Business stories from the print edition of today's Boston Globe.